Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Rubella (German Measles) - Overview
Rubella (German Measles) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Rubella (German Measles) - Therapeutics Assessment
Assessment by Route of Administration
Assessment by Molecule Type
Rubella (German Measles) - Companies Involved in Therapeutics Development
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
Cadila Healthcare Ltd
Daiichi Sankyo Co Ltd
Enesi Pharma Ltd
GlaxoSmithKline Plc
Indian Immunologicals Ltd
Micron Biomedical Inc
Sinovac Biotech Ltd
Univercells SA
Vaxxas Inc
Zhongyianke Biotech Co Ltd
Rubella (German Measles) - Drug Profiles
(measles + mumps + rubella + varicella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + mumps + rubella + varicella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + mumps + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + mumps + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles [strain Edmonstons-Zagreb] + rubella [strain RA-27]) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles [strain Schwarz] + mumps [strain RIT 4385] + rubella [strain Wistar RA 27/3]) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BK-1601 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rubella vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VN-0102 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Rubella (German Measles) - Dormant Projects
Rubella (German Measles) - Product Development Milestones
Featured News & Press Releases
Sep 01, 2020: Micron Biomedical progresses with clinical evaluation of its technology for measles-rubella vaccition
Mar 18, 2020: Vaxxas awarded US$5 million grant for clinical study of measles and rubella vaccition
Nov 30, 2019: Vaxxas was awarded research and development fund of USD 4,997,693 from Bill & Melinda Gates Foundation
Nov 30, 2016: Vaxxas was awarded research and development fund of USD 4,479,552 from Bill & Melinda Gates Foundation
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Rubella (German Measles), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Rubella (German Measles), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Rubella (German Measles) - Pipeline by Beijing Minhai Biotechnology Co Ltd, H2 2020
Rubella (German Measles) - Pipeline by Biological E Ltd, H2 2020
Rubella (German Measles) - Pipeline by Cadila Healthcare Ltd, H2 2020
Rubella (German Measles) - Pipeline by Daiichi Sankyo Co Ltd, H2 2020
Rubella (German Measles) - Pipeline by Enesi Pharma Ltd, H2 2020
Rubella (German Measles) - Pipeline by GlaxoSmithKline Plc, H2 2020
Rubella (German Measles) - Pipeline by Indian Immunologicals Ltd, H2 2020
Rubella (German Measles) - Pipeline by Micron Biomedical Inc, H2 2020
Rubella (German Measles) - Pipeline by Sinovac Biotech Ltd, H2 2020
Rubella (German Measles) - Pipeline by Univercells SA, H2 2020
Rubella (German Measles) - Pipeline by Vaxxas Inc, H2 2020
Rubella (German Measles) - Pipeline by Zhongyianke Biotech Co Ltd, H2 2020
Rubella (German Measles) - Dormant Projects, H2 2020